https://stock.noler.com/us/stock/item-9-labs-corp https://stock.noler.com/us/stock/item-9-labs-corp/accounts-and-notes-receivable-net https://stock.noler.com/us/stock/item-9-labs-corp/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/item-9-labs-corp/accounts-notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-and-accrued-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-fair-value-disclosure https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-interest-bearing-current https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-interest-bearing-interest-rate https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-interest-bearing-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-other-current https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-other-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accounts-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accounts-receivable https://stock.noler.com/us/stock/item-9-labs-corp/accounts-receivable-net-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/item-9-labs-corp/accounts-receivable-related-parties-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accounts-receivable-unapproved-contract-claims https://stock.noler.com/us/stock/item-9-labs-corp/accretion-expense-including-asset-retirement-obligations https://stock.noler.com/us/stock/item-9-labs-corp/accrued-bonuses-current https://stock.noler.com/us/stock/item-9-labs-corp/accrued-income-taxes-current https://stock.noler.com/us/stock/item-9-labs-corp/accrued-investment-income-receivable https://stock.noler.com/us/stock/item-9-labs-corp/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/accrued-liabilities-current https://stock.noler.com/us/stock/item-9-labs-corp/accrued-liabilities-for-commissions-expense-and-taxes https://stock.noler.com/us/stock/item-9-labs-corp/accrued-payroll-taxes-current https://stock.noler.com/us/stock/item-9-labs-corp/accrued-professional-fees-current https://stock.noler.com/us/stock/item-9-labs-corp/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accrued-rent-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accrued-rent-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/accrued-salaries-current https://stock.noler.com/us/stock/item-9-labs-corp/accumulated-depreciation https://stock.noler.com/us/stock/item-9-labs-corp/acquired-assets https://stock.noler.com/us/stock/item-9-labs-corp/acquired-cash-and-equivalents https://stock.noler.com/us/stock/item-9-labs-corp/acquired-current-assets-other https://stock.noler.com/us/stock/item-9-labs-corp/acquired-current-liabilities-accounts-payable https://stock.noler.com/us/stock/item-9-labs-corp/acquired-current-liabilities-long-term-debt https://stock.noler.com/us/stock/item-9-labs-corp/acquired-current-liabilities-other https://stock.noler.com/us/stock/item-9-labs-corp/acquired-finite-lived-intangible-asset-amount https://stock.noler.com/us/stock/item-9-labs-corp/acquired-indefinite-lived-intangible-assets https://stock.noler.com/us/stock/item-9-labs-corp/acquired-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/acquired-net https://stock.noler.com/us/stock/item-9-labs-corp/acquired-noncurrent-liabilities-other https://stock.noler.com/us/stock/item-9-labs-corp/acquired-other-noncurrent-assets https://stock.noler.com/us/stock/item-9-labs-corp/acquired-property-plant-and-equipment https://stock.noler.com/us/stock/item-9-labs-corp/acquisition-consideration-transferred https://stock.noler.com/us/stock/item-9-labs-corp/acquisition-consideration-transferred-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/item-9-labs-corp/acquisition-consideration-transferred-other https://stock.noler.com/us/stock/item-9-labs-corp/acquisition-separately-recognized-transactions-net-gains-and-losses https://stock.noler.com/us/stock/item-9-labs-corp/additional-paid-in-capital https://stock.noler.com/us/stock/item-9-labs-corp/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/item-9-labs-corp/additional-paid-in-capital-preferred-stock https://stock.noler.com/us/stock/item-9-labs-corp/adjustment-for-amortization https://stock.noler.com/us/stock/item-9-labs-corp/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/item-9-labs-corp/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/item-9-labs-corp/advertising-expense https://stock.noler.com/us/stock/item-9-labs-corp/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/item-9-labs-corp/allowance-for-doubtful-accounts-premiums-and-other-receivables https://stock.noler.com/us/stock/item-9-labs-corp/allowance-for-doubtful-accounts-receivable-charge-offs https://stock.noler.com/us/stock/item-9-labs-corp/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/item-9-labs-corp/allowance-for-loan-and-lease-loss-recovery-of-bad-debts https://stock.noler.com/us/stock/item-9-labs-corp/allowance-for-notes-and-loans-receivable-current https://stock.noler.com/us/stock/item-9-labs-corp/amortization https://stock.noler.com/us/stock/item-9-labs-corp/amortization-of-acquired-intangible-assets https://stock.noler.com/us/stock/item-9-labs-corp/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/item-9-labs-corp/amortization-of-deferred-sales-commissions https://stock.noler.com/us/stock/item-9-labs-corp/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/item-9-labs-corp/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/item-9-labs-corp/asset-impairment-charges https://stock.noler.com/us/stock/item-9-labs-corp/assets-held-for-sale-not-part-of-disposal-group https://stock.noler.com/us/stock/item-9-labs-corp/basic-shares https://stock.noler.com/us/stock/item-9-labs-corp/borrowed-funds https://stock.noler.com/us/stock/item-9-labs-corp/business-acquisition-cost-of-acquired-entity-liabilities-incurred https://stock.noler.com/us/stock/item-9-labs-corp/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/item-9-labs-corp/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/item-9-labs-corp/business-acquisition-purchase-price-allocation-current-liabilities-accounts-payable https://stock.noler.com/us/stock/item-9-labs-corp/business-acquisition-revenue-reported-by-acquired-entity-for-last-annual-period https://stock.noler.com/us/stock/item-9-labs-corp/business-acquisition-share-price https://stock.noler.com/us/stock/item-9-labs-corp/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/item-9-labs-corp/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/item-9-labs-corp/buyback-authorization https://stock.noler.com/us/stock/item-9-labs-corp/buybacks-payments-for-repurchase-of-other-equity https://stock.noler.com/us/stock/item-9-labs-corp/buybacks-shares-repurchased https://stock.noler.com/us/stock/item-9-labs-corp/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/item-9-labs-corp/buybacks-stock-repurchased-value https://stock.noler.com/us/stock/item-9-labs-corp/capital-expenditures https://stock.noler.com/us/stock/item-9-labs-corp/cash https://stock.noler.com/us/stock/item-9-labs-corp/cash-acquired-from-acquisition https://stock.noler.com/us/stock/item-9-labs-corp/cash-acquired-in-excess-of-payments-to-acquire-business https://stock.noler.com/us/stock/item-9-labs-corp/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/item-9-labs-corp/cash-and-equivalents https://stock.noler.com/us/stock/item-9-labs-corp/cash-and-restricted-cash https://stock.noler.com/us/stock/item-9-labs-corp/cash-change https://stock.noler.com/us/stock/item-9-labs-corp/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/item-9-labs-corp/cash-flow-breakdown https://stock.noler.com/us/stock/item-9-labs-corp/certain-loans-acquired-in-transfer-accounted-for-as-debt-securities-outstanding-balance https://stock.noler.com/us/stock/item-9-labs-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/item-9-labs-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/item-9-labs-corp/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/item-9-labs-corp/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/item-9-labs-corp/class-of-warrant-or-right-unissued https://stock.noler.com/us/stock/item-9-labs-corp/commitments-and-contingencies https://stock.noler.com/us/stock/item-9-labs-corp/common-shares-issued-employee-stock-trust https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-discount-on-shares https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-including-additional-paid-in-capital https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-no-par-value https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-other-shares-outstanding https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-other-value-outstanding https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-shares-held-in-employee-trust-shares https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-shares-subscribed-but-unissued https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-shares-subscriptions https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-value https://stock.noler.com/us/stock/item-9-labs-corp/common-stock-value-outstanding https://stock.noler.com/us/stock/item-9-labs-corp/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/item-9-labs-corp/concentration-risk-percentage https://stock.noler.com/us/stock/item-9-labs-corp/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/item-9-labs-corp/construction-in-progress-gross https://stock.noler.com/us/stock/item-9-labs-corp/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/item-9-labs-corp/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/item-9-labs-corp/convertible-debt https://stock.noler.com/us/stock/item-9-labs-corp/convertible-debt-current https://stock.noler.com/us/stock/item-9-labs-corp/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/item-9-labs-corp/convertible-debt-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/convertible-long-term-notes-payable https://stock.noler.com/us/stock/item-9-labs-corp/convertible-notes-payable https://stock.noler.com/us/stock/item-9-labs-corp/convertible-notes-payable-current https://stock.noler.com/us/stock/item-9-labs-corp/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/item-9-labs-corp/convertible-subordinated-debt https://stock.noler.com/us/stock/item-9-labs-corp/convertible-subordinated-debt-current https://stock.noler.com/us/stock/item-9-labs-corp/convertible-subordinated-debt-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/cost-of-merchandise-sales-buying-and-occupancy-costs https://stock.noler.com/us/stock/item-9-labs-corp/cost-of-revenue https://stock.noler.com/us/stock/item-9-labs-corp/cost-of-revenue-2 https://stock.noler.com/us/stock/item-9-labs-corp/costs-and-expenses https://stock.noler.com/us/stock/item-9-labs-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/item-9-labs-corp/current-assets https://stock.noler.com/us/stock/item-9-labs-corp/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/item-9-labs-corp/current-income-tax-expense-benefit https://stock.noler.com/us/stock/item-9-labs-corp/current-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/current-portion-of-long-term-debt https://stock.noler.com/us/stock/item-9-labs-corp/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/item-9-labs-corp/customer-deposits-current https://stock.noler.com/us/stock/item-9-labs-corp/debt-carrying-amount https://stock.noler.com/us/stock/item-9-labs-corp/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/item-9-labs-corp/debt-conversion-converted-instrument-rate https://stock.noler.com/us/stock/item-9-labs-corp/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/item-9-labs-corp/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/item-9-labs-corp/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/item-9-labs-corp/debt-conversion-original-debt-interest-rate-of-debt https://stock.noler.com/us/stock/item-9-labs-corp/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/item-9-labs-corp/debt-convertible-carrying-amount-of-the-equity-component https://stock.noler.com/us/stock/item-9-labs-corp/debt-convertible-conversion-price https://stock.noler.com/us/stock/item-9-labs-corp/debt-convertible-stock-price-trigger https://stock.noler.com/us/stock/item-9-labs-corp/debt-decrease-forgiveness https://stock.noler.com/us/stock/item-9-labs-corp/debt-default-longterm-debt-amount https://stock.noler.com/us/stock/item-9-labs-corp/debt-default-shortterm-debt-amount https://stock.noler.com/us/stock/item-9-labs-corp/debt-face-amount https://stock.noler.com/us/stock/item-9-labs-corp/debt-fair-value https://stock.noler.com/us/stock/item-9-labs-corp/debt-increase-accrued-interest https://stock.noler.com/us/stock/item-9-labs-corp/debt-increase-decrease-other-net https://stock.noler.com/us/stock/item-9-labs-corp/debt-interest-rate https://stock.noler.com/us/stock/item-9-labs-corp/debt-interest-rate-at-period-end https://stock.noler.com/us/stock/item-9-labs-corp/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/item-9-labs-corp/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/item-9-labs-corp/debt-issued https://stock.noler.com/us/stock/item-9-labs-corp/debt-longterm-and-shortterm-combined-amount https://stock.noler.com/us/stock/item-9-labs-corp/debt-periodic-payment-principal https://stock.noler.com/us/stock/item-9-labs-corp/debt-repaid https://stock.noler.com/us/stock/item-9-labs-corp/debt-unamortized-discount https://stock.noler.com/us/stock/item-9-labs-corp/debt-unamortized-discount-current https://stock.noler.com/us/stock/item-9-labs-corp/debt-unamortized-discount-premium-net https://stock.noler.com/us/stock/item-9-labs-corp/debt-unamortized-premium https://stock.noler.com/us/stock/item-9-labs-corp/deferred-compensation-arrangement-with-individual-allocated-share-based-compensation-expense https://stock.noler.com/us/stock/item-9-labs-corp/deferred-compensation-arrangement-with-individual-common-stock-reserved-for-future-issuance https://stock.noler.com/us/stock/item-9-labs-corp/deferred-compensation-arrangement-with-individual-shares-authorized-for-issuance https://stock.noler.com/us/stock/item-9-labs-corp/deferred-compensation-plan-assets https://stock.noler.com/us/stock/item-9-labs-corp/deferred-costs-current https://stock.noler.com/us/stock/item-9-labs-corp/deferred-credits-and-other-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/deferred-credits-and-other-liabilities-current https://stock.noler.com/us/stock/item-9-labs-corp/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/item-9-labs-corp/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/item-9-labs-corp/deferred-offering-costs https://stock.noler.com/us/stock/item-9-labs-corp/deferred-revenue https://stock.noler.com/us/stock/item-9-labs-corp/deferred-revenue-2 https://stock.noler.com/us/stock/item-9-labs-corp/deferred-revenue-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/item-9-labs-corp/deferred-sales-commission https://stock.noler.com/us/stock/item-9-labs-corp/deferred-sales-inducements-amortization-expense https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-asset-interest-carryforward https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-gross https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-other https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-tax-deferred-expense https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-impairment-losses https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/item-9-labs-corp/deferred-tax-liabilities-interests-in-financial-assets-continued-to-be-held https://stock.noler.com/us/stock/item-9-labs-corp/deposit-assets https://stock.noler.com/us/stock/item-9-labs-corp/deposit-assets-or-liabilities-effect-of-change-in-present-value-assumptions-recorded-as-expense https://stock.noler.com/us/stock/item-9-labs-corp/deposit-liabilities-accrued-interest https://stock.noler.com/us/stock/item-9-labs-corp/deposits https://stock.noler.com/us/stock/item-9-labs-corp/deposits-assets-current https://stock.noler.com/us/stock/item-9-labs-corp/deposits-assets-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/depreciation https://stock.noler.com/us/stock/item-9-labs-corp/depreciation-and-amortization https://stock.noler.com/us/stock/item-9-labs-corp/depreciation-and-amortization-expense https://stock.noler.com/us/stock/item-9-labs-corp/derivative-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/item-9-labs-corp/diluted-shares https://stock.noler.com/us/stock/item-9-labs-corp/dilutive-shares https://stock.noler.com/us/stock/item-9-labs-corp/disposal-group-including-discontinued-operation-accounts-payable-current https://stock.noler.com/us/stock/item-9-labs-corp/disposal-group-including-discontinued-operation-costs-of-goods-sold https://stock.noler.com/us/stock/item-9-labs-corp/disposal-group-including-discontinued-operation-operating-income-loss https://stock.noler.com/us/stock/item-9-labs-corp/disposal-group-including-discontinued-operation-revenue https://stock.noler.com/us/stock/item-9-labs-corp/dividends-per-share https://stock.noler.com/us/stock/item-9-labs-corp/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/item-9-labs-corp/due-to-other-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/due-to-related-parties-current https://stock.noler.com/us/stock/item-9-labs-corp/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/item-9-labs-corp/effective-tax-rate https://stock.noler.com/us/stock/item-9-labs-corp/employee-related-liabilities-current https://stock.noler.com/us/stock/item-9-labs-corp/employee-stock-ownership-plan-esop-compensation-expense https://stock.noler.com/us/stock/item-9-labs-corp/entity-listing-par-value-per-share https://stock.noler.com/us/stock/item-9-labs-corp/eps https://stock.noler.com/us/stock/item-9-labs-corp/eps-basic https://stock.noler.com/us/stock/item-9-labs-corp/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/item-9-labs-corp/equity-method-investments https://stock.noler.com/us/stock/item-9-labs-corp/escrow-deposit https://stock.noler.com/us/stock/item-9-labs-corp/escrow-deposits-related-to-property-sales https://stock.noler.com/us/stock/item-9-labs-corp/excess-stock-shares-authorized https://stock.noler.com/us/stock/item-9-labs-corp/excess-stock-shares-issued https://stock.noler.com/us/stock/item-9-labs-corp/excess-stock-shares-outstanding https://stock.noler.com/us/stock/item-9-labs-corp/extinguishment-of-debt-amount https://stock.noler.com/us/stock/item-9-labs-corp/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/item-9-labs-corp/fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/item-9-labs-corp/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/item-9-labs-corp/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/item-9-labs-corp/fair-value-of-assets-acquired https://stock.noler.com/us/stock/item-9-labs-corp/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/item-9-labs-corp/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/item-9-labs-corp/financial-instruments-owned-corporate-equities-at-fair-value https://stock.noler.com/us/stock/item-9-labs-corp/financing-cash-flow https://stock.noler.com/us/stock/item-9-labs-corp/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/item-9-labs-corp/finite-lived-intangible-assets-fair-value-disclosure https://stock.noler.com/us/stock/item-9-labs-corp/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/item-9-labs-corp/finite-lived-license-agreements-gross https://stock.noler.com/us/stock/item-9-labs-corp/finitelived-intangible-assets-acquired https://stock.noler.com/us/stock/item-9-labs-corp/form-d-other https://stock.noler.com/us/stock/item-9-labs-corp/form-d-stocks https://stock.noler.com/us/stock/item-9-labs-corp/furniture-and-fixtures-gross https://stock.noler.com/us/stock/item-9-labs-corp/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/item-9-labs-corp/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/item-9-labs-corp/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/item-9-labs-corp/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/item-9-labs-corp/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/item-9-labs-corp/gain-loss-on-investments-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/item-9-labs-corp/gain-loss-on-sale-of-equity-investments https://stock.noler.com/us/stock/item-9-labs-corp/gain-loss-on-sale-of-other-assets https://stock.noler.com/us/stock/item-9-labs-corp/gain-loss-on-sales-of-assets-and-asset-impairment-charges https://stock.noler.com/us/stock/item-9-labs-corp/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/item-9-labs-corp/gains-losses-on-extinguishment-of-debt-before-write-off-of-deferred-debt-issuance-cost https://stock.noler.com/us/stock/item-9-labs-corp/gains-losses-on-sales-of-assets https://stock.noler.com/us/stock/item-9-labs-corp/general-and-administrative-expense https://stock.noler.com/us/stock/item-9-labs-corp/goodwill https://stock.noler.com/us/stock/item-9-labs-corp/goodwill-acquired https://stock.noler.com/us/stock/item-9-labs-corp/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/item-9-labs-corp/goodwill-impairment-loss https://stock.noler.com/us/stock/item-9-labs-corp/gross-profit https://stock.noler.com/us/stock/item-9-labs-corp/held-to-maturity-securities-debt-maturities-without-single-maturity-date-net-carrying-amount https://stock.noler.com/us/stock/item-9-labs-corp/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/item-9-labs-corp/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/item-9-labs-corp/impairment-of-investments https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-attributable-to-parent https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-from https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-from-before-interest-expense-interest-income-income-taxes-extraordinary-items-noncontrolling-interests-net https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-from-per-basic-share https://stock.noler.com/us/stock/item-9-labs-corp/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/item-9-labs-corp/income-tax https://stock.noler.com/us/stock/item-9-labs-corp/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-accrued-salaries https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-accrued-taxes-payable https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-customer-loyalty-program-liability https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-deposits https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-due-to-other-related-parties https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-earnest-money-deposits-outstanding https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-inventories https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-notes-payable-current https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-notes-payable-related-parties https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-notes-payable-related-parties-current https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-notes-receivable-related-parties https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/item-9-labs-corp/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/item-9-labs-corp/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/item-9-labs-corp/incremental-common-shares-attributable-to-written-put-options https://stock.noler.com/us/stock/item-9-labs-corp/indefinitelived-intangible-assets-acquired https://stock.noler.com/us/stock/item-9-labs-corp/induced-conversion-of-convertible-debt-expense https://stock.noler.com/us/stock/item-9-labs-corp/insider-transactions-corporate-securities https://stock.noler.com/us/stock/item-9-labs-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/item-9-labs-corp/insider-transactions-warrants https://stock.noler.com/us/stock/item-9-labs-corp/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/item-9-labs-corp/interest-and-debt-expense https://stock.noler.com/us/stock/item-9-labs-corp/interest-expense https://stock.noler.com/us/stock/item-9-labs-corp/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/item-9-labs-corp/interest-expense-on-debt https://stock.noler.com/us/stock/item-9-labs-corp/interest-expense-other-long-term-debt https://stock.noler.com/us/stock/item-9-labs-corp/interest-expense-related-party https://stock.noler.com/us/stock/item-9-labs-corp/interest-expense-trading-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/interest-income-expense-net https://stock.noler.com/us/stock/item-9-labs-corp/interest-income-operating https://stock.noler.com/us/stock/item-9-labs-corp/interest-paid https://stock.noler.com/us/stock/item-9-labs-corp/interest-paid-net https://stock.noler.com/us/stock/item-9-labs-corp/interest-payable-current https://stock.noler.com/us/stock/item-9-labs-corp/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/interest-receivable https://stock.noler.com/us/stock/item-9-labs-corp/inventory https://stock.noler.com/us/stock/item-9-labs-corp/inventory-finished-goods https://stock.noler.com/us/stock/item-9-labs-corp/inventory-lifo-reserve-period-charge https://stock.noler.com/us/stock/item-9-labs-corp/inventory-parts-and-components-net-of-reserves https://stock.noler.com/us/stock/item-9-labs-corp/inventory-work-in-process-and-raw-materials https://stock.noler.com/us/stock/item-9-labs-corp/investing-cash-flow https://stock.noler.com/us/stock/item-9-labs-corp/investment-owned-balance-shares https://stock.noler.com/us/stock/item-9-labs-corp/investment-sold-not-yet-purchased-balance-shares https://stock.noler.com/us/stock/item-9-labs-corp/investment-warrants-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/investments-in-affiliates-subsidiaries-associates-and-joint-ventures-fair-value-disclosure https://stock.noler.com/us/stock/item-9-labs-corp/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/item-9-labs-corp/labor-and-related-expense https://stock.noler.com/us/stock/item-9-labs-corp/land https://stock.noler.com/us/stock/item-9-labs-corp/lease-and-rental-expense https://stock.noler.com/us/stock/item-9-labs-corp/legal-fees https://stock.noler.com/us/stock/item-9-labs-corp/liabilities-assumed https://stock.noler.com/us/stock/item-9-labs-corp/liabilities-fair-value-adjustment https://stock.noler.com/us/stock/item-9-labs-corp/liability-for-unpaid-claims-and-claims-adjustment-expense-net https://stock.noler.com/us/stock/item-9-labs-corp/license-costs https://stock.noler.com/us/stock/item-9-labs-corp/line-of-credit https://stock.noler.com/us/stock/item-9-labs-corp/line-of-credit-assumed https://stock.noler.com/us/stock/item-9-labs-corp/line-of-credit-facility-average-outstanding-amount https://stock.noler.com/us/stock/item-9-labs-corp/line-of-credit-facility-commitment-fee-percentage https://stock.noler.com/us/stock/item-9-labs-corp/line-of-credit-facility-current-borrowing-capacity https://stock.noler.com/us/stock/item-9-labs-corp/line-of-credit-facility-increase-decrease-for-period-net https://stock.noler.com/us/stock/item-9-labs-corp/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/item-9-labs-corp/lines-of-credit-current https://stock.noler.com/us/stock/item-9-labs-corp/litigation-settlement-amount https://stock.noler.com/us/stock/item-9-labs-corp/loans-assumed https://stock.noler.com/us/stock/item-9-labs-corp/loans-payable https://stock.noler.com/us/stock/item-9-labs-corp/loans-payable-current https://stock.noler.com/us/stock/item-9-labs-corp/loans-payable-fair-value-disclosure https://stock.noler.com/us/stock/item-9-labs-corp/long-duration-contracts-assumptions-by-product-and-guarantee-other-rate https://stock.noler.com/us/stock/item-9-labs-corp/long-term-debt https://stock.noler.com/us/stock/item-9-labs-corp/longterm-debt-weighted-average-interest-rate https://stock.noler.com/us/stock/item-9-labs-corp/machinery-and-equipment-gross https://stock.noler.com/us/stock/item-9-labs-corp/marketing-expense https://stock.noler.com/us/stock/item-9-labs-corp/minority-interest https://stock.noler.com/us/stock/item-9-labs-corp/net-change-in-cash https://stock.noler.com/us/stock/item-9-labs-corp/net-income https://stock.noler.com/us/stock/item-9-labs-corp/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/item-9-labs-corp/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-accounts-receivable-acquired https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-net-nonmonetary-assets-acquired-liabilities-assumed https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-options-issued https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-shares-issued https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-warrants-issued https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-other-assets-acquired https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-other-liabilities-assumed https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-payables-assumed https://stock.noler.com/us/stock/item-9-labs-corp/noncash-or-part-noncash-acquisition-value-of-liabilities-assumed https://stock.noler.com/us/stock/item-9-labs-corp/notes-and-loans-payable https://stock.noler.com/us/stock/item-9-labs-corp/notes-and-loans-payable-current https://stock.noler.com/us/stock/item-9-labs-corp/notes-and-loans-receivable-gross-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/item-9-labs-corp/notes-and-loans-receivable-net-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/notes-assumed https://stock.noler.com/us/stock/item-9-labs-corp/notes-payable https://stock.noler.com/us/stock/item-9-labs-corp/notes-payable-current https://stock.noler.com/us/stock/item-9-labs-corp/notes-payable-fair-value-disclosure https://stock.noler.com/us/stock/item-9-labs-corp/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/item-9-labs-corp/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/notes-receivable-fair-value-disclosure https://stock.noler.com/us/stock/item-9-labs-corp/notes-receivable-gross https://stock.noler.com/us/stock/item-9-labs-corp/notes-receivable-net https://stock.noler.com/us/stock/item-9-labs-corp/notes-receivable-related-parties https://stock.noler.com/us/stock/item-9-labs-corp/notes-receivable-related-parties-current https://stock.noler.com/us/stock/item-9-labs-corp/notes-receivable-related-parties-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/oci-before-tax https://stock.noler.com/us/stock/item-9-labs-corp/oci-net-of-tax-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/item-9-labs-corp/officers-compensation https://stock.noler.com/us/stock/item-9-labs-corp/operating-cash-flow https://stock.noler.com/us/stock/item-9-labs-corp/operating-expenses https://stock.noler.com/us/stock/item-9-labs-corp/operating-income https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-assets https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-cost https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-impairment-loss https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-liability-current https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-payments https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-payments-due https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-payments-due-current https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/item-9-labs-corp/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/item-9-labs-corp/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/item-9-labs-corp/operating-leases-rent-expense-net https://stock.noler.com/us/stock/item-9-labs-corp/operating-loss-carryforwards https://stock.noler.com/us/stock/item-9-labs-corp/operating-loss-carryforwards-valuation-allowance https://stock.noler.com/us/stock/item-9-labs-corp/option-indexed-to-issuers-equity-indexed-shares https://stock.noler.com/us/stock/item-9-labs-corp/option-indexed-to-issuers-equity-settlement-alternatives-shares-at-fair-value https://stock.noler.com/us/stock/item-9-labs-corp/other-accrued-liabilities-current https://stock.noler.com/us/stock/item-9-labs-corp/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/other-asset-impairment-charges https://stock.noler.com/us/stock/item-9-labs-corp/other-assets https://stock.noler.com/us/stock/item-9-labs-corp/other-commitment https://stock.noler.com/us/stock/item-9-labs-corp/other-cost-and-expense-operating https://stock.noler.com/us/stock/item-9-labs-corp/other-current-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/other-expenses https://stock.noler.com/us/stock/item-9-labs-corp/other-general-and-administrative-expense https://stock.noler.com/us/stock/item-9-labs-corp/other-income https://stock.noler.com/us/stock/item-9-labs-corp/other-income-2 https://stock.noler.com/us/stock/item-9-labs-corp/other-loans-payable https://stock.noler.com/us/stock/item-9-labs-corp/other-long-term-notes-payable https://stock.noler.com/us/stock/item-9-labs-corp/other-noncash-expense https://stock.noler.com/us/stock/item-9-labs-corp/other-noncurrent-assets https://stock.noler.com/us/stock/item-9-labs-corp/other-nonoperating-gains-losses https://stock.noler.com/us/stock/item-9-labs-corp/other-nonoperating-income https://stock.noler.com/us/stock/item-9-labs-corp/other-nonoperating-income-expense https://stock.noler.com/us/stock/item-9-labs-corp/other-notes-payable https://stock.noler.com/us/stock/item-9-labs-corp/other-operating-income https://stock.noler.com/us/stock/item-9-labs-corp/other-ownership-interests-units-outstanding https://stock.noler.com/us/stock/item-9-labs-corp/other-payments-to-acquire-businesses https://stock.noler.com/us/stock/item-9-labs-corp/other-prepaid-expense-current https://stock.noler.com/us/stock/item-9-labs-corp/other-secured-financings https://stock.noler.com/us/stock/item-9-labs-corp/other-selling-and-marketing-expense https://stock.noler.com/us/stock/item-9-labs-corp/other-selling-general-and-administrative-expense https://stock.noler.com/us/stock/item-9-labs-corp/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/item-9-labs-corp/paid-in-capital-other https://stock.noler.com/us/stock/item-9-labs-corp/paid-in-capital-share-based-compensation-and-exercise-of-stock-options https://stock.noler.com/us/stock/item-9-labs-corp/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/item-9-labs-corp/partners-capital-account-units-sold-in-private-placement https://stock.noler.com/us/stock/item-9-labs-corp/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/item-9-labs-corp/payments-for-deposits-on-real-estate-acquisitions https://stock.noler.com/us/stock/item-9-labs-corp/payments-for-fees https://stock.noler.com/us/stock/item-9-labs-corp/payments-for-legal-settlements https://stock.noler.com/us/stock/item-9-labs-corp/payments-of-financing-costs https://stock.noler.com/us/stock/item-9-labs-corp/payments-of-loan-costs https://stock.noler.com/us/stock/item-9-labs-corp/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/item-9-labs-corp/payments-to-acquire-available-for-sale-equity https://stock.noler.com/us/stock/item-9-labs-corp/payments-to-acquire-businesses-and-interest-in-affiliates https://stock.noler.com/us/stock/item-9-labs-corp/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/item-9-labs-corp/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/item-9-labs-corp/payments-to-acquire-land-held-for-use https://stock.noler.com/us/stock/item-9-labs-corp/payments-to-acquire-notes-receivable https://stock.noler.com/us/stock/item-9-labs-corp/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/item-9-labs-corp/postconfirmation-furniture-and-fixtures https://stock.noler.com/us/stock/item-9-labs-corp/postconfirmation-retained-earnings-deficit https://stock.noler.com/us/stock/item-9-labs-corp/preferred-shares-facts https://stock.noler.com/us/stock/item-9-labs-corp/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/item-9-labs-corp/prepaid-advertising https://stock.noler.com/us/stock/item-9-labs-corp/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/item-9-labs-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/item-9-labs-corp/prepaid-expense-current https://stock.noler.com/us/stock/item-9-labs-corp/prepaid-expense-other-noncurrent https://stock.noler.com/us/stock/item-9-labs-corp/prepaid-insurance https://stock.noler.com/us/stock/item-9-labs-corp/prepaid-interest https://stock.noler.com/us/stock/item-9-labs-corp/prepaid-rent https://stock.noler.com/us/stock/item-9-labs-corp/pretax-income-domestic https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-accounts-receivable-securitization https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-advances-for-construction https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-collection-of-notes-receivable https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-convertible-debt https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-deposits-from-customers https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-issuance-of-medium-term-notes https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-notes-payable https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-related-party-debt https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-repayments-of-accounts-receivable-securitization https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-sale-of-other-assets-investing-activities https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-sale-of-other-property-plant-and-equipment https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-secured-notes-payable https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/item-9-labs-corp/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/item-9-labs-corp/product-liability-contingency-third-party-recovery https://stock.noler.com/us/stock/item-9-labs-corp/production-related-impairments-or-charges https://stock.noler.com/us/stock/item-9-labs-corp/professional-and-contract-services-expense https://stock.noler.com/us/stock/item-9-labs-corp/professional-fees https://stock.noler.com/us/stock/item-9-labs-corp/property-plant-and-equipment-additions https://stock.noler.com/us/stock/item-9-labs-corp/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/item-9-labs-corp/property-plant-and-equipment-fair-value-disclosure https://stock.noler.com/us/stock/item-9-labs-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/item-9-labs-corp/property-plant-and-equipment-other https://stock.noler.com/us/stock/item-9-labs-corp/property-plant-and-equipment-other-net https://stock.noler.com/us/stock/item-9-labs-corp/property-plant-equipment https://stock.noler.com/us/stock/item-9-labs-corp/provision-for-doubtful-accounts https://stock.noler.com/us/stock/item-9-labs-corp/public-float https://stock.noler.com/us/stock/item-9-labs-corp/purchase-obligation https://stock.noler.com/us/stock/item-9-labs-corp/recapitalization-costs https://stock.noler.com/us/stock/item-9-labs-corp/receivables-net-current https://stock.noler.com/us/stock/item-9-labs-corp/recorded-unconditional-purchase-obligation https://stock.noler.com/us/stock/item-9-labs-corp/recorded-unconditional-purchase-obligation-due-in-remainder-of-fiscal-year https://stock.noler.com/us/stock/item-9-labs-corp/rental-income-nonoperating https://stock.noler.com/us/stock/item-9-labs-corp/repayments-of-convertible-debt https://stock.noler.com/us/stock/item-9-labs-corp/repayments-of-debt https://stock.noler.com/us/stock/item-9-labs-corp/repayments-of-notes-payable https://stock.noler.com/us/stock/item-9-labs-corp/repayments-of-other-debt https://stock.noler.com/us/stock/item-9-labs-corp/repayments-of-related-party-debt https://stock.noler.com/us/stock/item-9-labs-corp/repayments-of-short-term-debt https://stock.noler.com/us/stock/item-9-labs-corp/research-and-development https://stock.noler.com/us/stock/item-9-labs-corp/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/item-9-labs-corp/retail-related-inventory-packaging-and-other-supplies https://stock.noler.com/us/stock/item-9-labs-corp/retained-earnings https://stock.noler.com/us/stock/item-9-labs-corp/revenue https://stock.noler.com/us/stock/item-9-labs-corp/salaries-wages-and-officers-compensation https://stock.noler.com/us/stock/item-9-labs-corp/sale-leaseback-transaction-annual-rental-payments https://stock.noler.com/us/stock/item-9-labs-corp/sale-leaseback-transaction-monthly-rental-payments https://stock.noler.com/us/stock/item-9-labs-corp/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/item-9-labs-corp/sale-of-stock-consideration-received-per-transaction https://stock.noler.com/us/stock/item-9-labs-corp/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/item-9-labs-corp/sale-of-stock-price-per-share https://stock.noler.com/us/stock/item-9-labs-corp/sales-returns-and-allowances-goods https://stock.noler.com/us/stock/item-9-labs-corp/sales-returns-goods https://stock.noler.com/us/stock/item-9-labs-corp/sales-revenue-goods-gross https://stock.noler.com/us/stock/item-9-labs-corp/securities-borrowed-fair-value-disclosure https://stock.noler.com/us/stock/item-9-labs-corp/securitized-assets-and-any-other-financial-assets-managed-together-delinquent-amount-at-end-of-period https://stock.noler.com/us/stock/item-9-labs-corp/security-deposit https://stock.noler.com/us/stock/item-9-labs-corp/selling-and-marketing-expense https://stock.noler.com/us/stock/item-9-labs-corp/selling-expense https://stock.noler.com/us/stock/item-9-labs-corp/settlement-liabilities-current https://stock.noler.com/us/stock/item-9-labs-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/item-9-labs-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/item-9-labs-corp/share-based-goods-and-nonemployee-services-transaction-valuation-method-expected-dividend-rate https://stock.noler.com/us/stock/item-9-labs-corp/share-price https://stock.noler.com/us/stock/item-9-labs-corp/shareholders-equity https://stock.noler.com/us/stock/item-9-labs-corp/shares-authorized https://stock.noler.com/us/stock/item-9-labs-corp/shares-issued https://stock.noler.com/us/stock/item-9-labs-corp/shares-issued-2 https://stock.noler.com/us/stock/item-9-labs-corp/shares-issued-shares-stock-splits https://stock.noler.com/us/stock/item-9-labs-corp/shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/item-9-labs-corp/shares-outstanding-2 https://stock.noler.com/us/stock/item-9-labs-corp/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/item-9-labs-corp/short-term-borrowings https://stock.noler.com/us/stock/item-9-labs-corp/short-term-debt https://stock.noler.com/us/stock/item-9-labs-corp/short-term-non-bank-loans-and-notes-payable https://stock.noler.com/us/stock/item-9-labs-corp/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/item-9-labs-corp/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-compensation-cost https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-non-option-equity-instruments-forfeitures-and-expirations https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-per-share-weighted-average-price-of-shares-purchased https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-rsu-nonvested-intrinsic-value https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/item-9-labs-corp/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/item-9-labs-corp/stock-based-compensation https://stock.noler.com/us/stock/item-9-labs-corp/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/item-9-labs-corp/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/item-9-labs-corp/stock-granted-value-share-based-compensation https://stock.noler.com/us/stock/item-9-labs-corp/stock-granted-value-share-based-compensation-forfeited https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-for-stock-awards https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-shares-change https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-shares-conversion-of-units https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-shares-issued-for-noncash-consideration https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-value-dividend-reinvestment-plan https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-value-issued-for-noncash-considerations https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/item-9-labs-corp/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-exercisable-number https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-grants-in-period https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-grants-in-period-grant-date-intrinsic-value https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-outstanding-change-average-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-outstanding-number https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/item-9-labs-corp/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/item-9-labs-corp/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/item-9-labs-corp/stock-repurchase-program-remaining-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/item-9-labs-corp/stockholders-equity-before-treasury-stock https://stock.noler.com/us/stock/item-9-labs-corp/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/item-9-labs-corp/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/item-9-labs-corp/stockholders-equity-other-shares https://stock.noler.com/us/stock/item-9-labs-corp/subsidiary-or-equity-method-investee-price-per-share https://stock.noler.com/us/stock/item-9-labs-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/item-9-labs-corp/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/item-9-labs-corp/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/item-9-labs-corp/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/item-9-labs-corp/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/item-9-labs-corp/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/item-9-labs-corp/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/item-9-labs-corp/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/item-9-labs-corp/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/item-9-labs-corp/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/item-9-labs-corp/taxes-payable-current https://stock.noler.com/us/stock/item-9-labs-corp/technology-services-costs https://stock.noler.com/us/stock/item-9-labs-corp/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/item-9-labs-corp/temporary-equity-redemption-price-per-share https://stock.noler.com/us/stock/item-9-labs-corp/temporary-equity-redemption-value https://stock.noler.com/us/stock/item-9-labs-corp/temporary-equity-shares-issued https://stock.noler.com/us/stock/item-9-labs-corp/total-assets https://stock.noler.com/us/stock/item-9-labs-corp/total-liabilities https://stock.noler.com/us/stock/item-9-labs-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/item-9-labs-corp/total-long-term-debt https://stock.noler.com/us/stock/item-9-labs-corp/treasury-shares-acquired https://stock.noler.com/us/stock/item-9-labs-corp/treasury-stock-retired-par-value-method-amount https://stock.noler.com/us/stock/item-9-labs-corp/treasury-stock-shares https://stock.noler.com/us/stock/item-9-labs-corp/treasury-stock-value https://stock.noler.com/us/stock/item-9-labs-corp/troubled-debt-restructuring-debtor-current-period-gain-loss-on-restructuring-net-of-tax https://stock.noler.com/us/stock/item-9-labs-corp/trustee-fees https://stock.noler.com/us/stock/item-9-labs-corp/undistributed-earnings-diluted https://stock.noler.com/us/stock/item-9-labs-corp/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/item-9-labs-corp/valuation-allowances-and-reserves-change https://stock.noler.com/us/stock/item-9-labs-corp/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/item-9-labs-corp/variable-interest-entity-consolidated-assets-current https://stock.noler.com/us/stock/item-9-labs-corp/variable-interest-entity-ownership-percentage https://stock.noler.com/us/stock/item-9-labs-corp/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/item-9-labs-corp/weighted-average-number-of-shares-issued-basic